Noradrenalin can regulate progression of Alzheimer`s disease

Bonn, 15th March 2010 Noradrenalin reduces inflammation in the nervous system and regulates the removal of β-Amyloid in microglial cells, this what Professor Michael Heneka and colleagues of the “Deutschen Zentrum für Neurodegenerative Erkrankungen” and the University of Bonn show. With this publication, the scientist show a new therapeutic approach to delay the onset of the Alzheimer`s disease. Inflammations and the aggregation of β-Amyloid are thought to be the causes of the disease. The scientists publish their results in the magazine “Proceedings of the National Academy of Sciences“ (online publication).

more...

Contact:
Prof. Dr. Michael T. Heneka
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
Universität Bonn
+49 (0228) 287 13092
michael.heneka@ukb.uni-bonn.de

Sonja Jülich-Abbas
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
DZNE Public Relations
+49 (228) 30899-225
+49 (172) 2838930
sonja.juelich-abbas@dzne.de

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: